Purna Pharmaceuticals SA

182.6 FTE

Purna Pharmaceuticals reported revenue of €43.2m for the 2025 financial year (annual accounts filed with the NBB on 05 Jun 2026), with 182.6 full-time equivalents.

Company number (CBE) 0428.742.176 · VAT BE0428742176
2870 Puurs-Sint-Amands
active in Manufacture of medicaments (NACE 21201)
operating since 04 Apr 1986 (≈ 40 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Purna Pharmaceuticals shows with a free account.

See the score
Profile
SA Medium · 182.6 FTE since 1986
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue€43.2m
Net result€2.82m
Equity€19.4m
Cash173,324 €
EBITDA€6.52m
Total assets€34.3m
Headcount (avg FTE)182.6
The line marks its sector median: 47.2% (76 companies).

Change 2022 → 2025: Revenue +16 % Equity +137 % Total assets +28 % Headcount (avg FTE) -4 %

Accounts of the company itself (not consolidated).

The full file covers 16 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Purna Pharmaceuticals's annual accounts

20252024202320222021
Revenue€43.2m
Net result€2.82m
Equity€19.4m
Cash173,324 €
EBITDA€6.52m
Total assets€34.3m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 05 Jun 2026
  • Year ended 31 Dec 2024filed on 22 May 2025
  • Year ended 31 Dec 2023filed on 07 Jun 2024
  • Year ended 31 Dec 2022filed on 19 May 2023
  • Year ended 31 Dec 2021filed on 13 Jun 2022

Purna Pharmaceuticals's financial analysis

Management and control of Purna Pharmaceuticals

1 active director(s) in the register.

Purna Pharmaceuticals's shareholders and holdings →

Purna Pharmaceuticals's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0428.742.176
VAT number
BE0428742176
Peppol
Registered · 0208:0428742176 · as of 10 Nov 2026
Legal form
SA
Incorporated
04 Apr 1986
Registered office
2870 Puurs-Sint-Amands
Size
Medium · 182.6 FTE
Latest accounts
2025 · filed on 05 Jun 2026
Activity
Manufacture of medicaments (NACE 21201)

Purna Pharmaceuticals (SA) has been based in Puurs-Sint-Amands since 1986, active in: manufacture of medicaments. For 2025, it reports revenue of €43.2m, a net profit of €2.82m and equity of €19.4m. With 182.6 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 56.5%, above the median of its sector (47.2%).

Guide: Checking a Belgian supplier invoice: numbers and IBAN →

Companies similar to Purna Pharmaceuticals

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Purna Pharmaceuticals

What is the revenue of Purna Pharmaceuticals?

According to the 2025 annual accounts filed with the NBB, the revenue of Purna Pharmaceuticals amounts to 43,231,454 €.

What is the VAT number of Purna Pharmaceuticals?

In Belgium, the VAT number is the company number prefixed with BE: BE0428742176 for Purna Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0428.742.176.

Where is the registered office of Purna Pharmaceuticals?

According to the CBE register, the registered office of Purna Pharmaceuticals is in 2870 Puurs-Sint-Amands.

What is the equity of Purna Pharmaceuticals?

At the close of the 2025 financial year, the equity of Purna Pharmaceuticals amounts to 19,386,429 €, a solvency of 56.5% of total assets.

How many people work at Purna Pharmaceuticals?

182.6 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Purna Pharmaceuticals?

The register lists 1 active mandates at Purna Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Purna Pharmaceuticals

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 20 Jul 2026

No credit card, no commitment.

What each plan unlocks →